User contributions
- 17:31, 21 October 2021 (diff | hist) . . (+1) . . Part:BBa M36071 (→Improved:SZU-China 2021:The addition of signal peptides) (current)
- 17:31, 21 October 2021 (diff | hist) . . (+32) . . Part:BBa M36071 (→Improved:SZU-China 2021:The addition of signal peptides)
- 17:27, 21 October 2021 (diff | hist) . . (+6,829) . . Part:BBa M36071 (→Improved:SZU-China 2021:The addition of signal peptides)
- 16:58, 21 October 2021 (diff | hist) . . (0) . . N File:T--SZU-China--POCll37.png (current)
- 16:57, 21 October 2021 (diff | hist) . . (+244) . . Part:BBa K875009 (→SZU-China 2021:LL37 Inflammation suppression effect) (current)
- 16:11, 21 October 2021 (diff | hist) . . (0) . . N File:T--SZU-China--resultLL37SDSPAGE4.png (current)
- 16:10, 21 October 2021 (diff | hist) . . (0) . . Part:BBa K3838555 (current)
- 15:14, 21 October 2021 (diff | hist) . . (+1) . . Part:BBa K3838555
- 14:47, 21 October 2021 (diff | hist) . . (-39) . . Part:BBa K3838555
- 14:45, 21 October 2021 (diff | hist) . . (+39) . . Part:BBa K3838555
- 14:44, 21 October 2021 (diff | hist) . . (+1,382) . . Part:BBa K3838555
- 14:42, 21 October 2021 (diff | hist) . . (-1,723) . . Part:BBa K3838555